Table 2. Known HPO-gene-MOI relationships used to benchmark Phenogenon.
Rank | Gene | HPO | MOI | NP | M score | HGF score |
---|---|---|---|---|---|---|
1 | SCN1A | Seizures | Dom | 100 | Dom | 64.43 |
2 | USH2A | Visual impairment | Rec | 259 | Rec | 26.20 |
3 | ABCA4 | Macular dystrophy | Rec | 76 | Rec | 16.78 |
4 | CNGB1 | Constriction of the peripheral visual field | Rec | 41 | Rec | 9.43 |
5 | CERKL | Nyctalopia | Rec | 15 | Rec | 8.25 |
6 | PROM1 | Macular dystrophy | Dom | 60 | Dom | 7.02 |
7 | GUCY2D | Visual loss | Rec | 8 | Rec | 6.82 |
8 | CRB1 | Retinal dystrophy | Rec | 25 | Rec | 6.75 |
9 | TERT | Bone marrow hypocellularity | Dom | 48 | Dom | 6.28 |
10 | BBS1 | Constriction of the peripheral visual field | Rec | 10 | Rec | 5.61 |
11 | RPGR | Constriction of the peripheral visual field | X-linked | 28 | Rec | 4.77 |
12 | IMPG2 | Visual loss | Rec | 4 | Rec | 2.51 |
MOI = Mode of Inheritance; NP = the number of patients who carry rare variants for the corresponding MOI